maria abellas: "the most difficult cases - report of a clinical case"
Published 7 years ago • 108 plays • Length 0:44Download video MP4
Download video MP3
Similar videos
-
0:56
the “controversial situations” seen in flt3-mutated aml patients
-
1:04
flt3 inhibitors – an ideal strategy for treating flt3-mutated aml
-
1:08
the tumor-myeloid axis as a predictor of response to immunotherapy in nsclc
-
1:54
safety and efficacy of glasdegib for r/r aml
-
2:44
azacitidine, venetoclax & gilteritinib in older/unfit patients with flt3-mutated aml
-
0:59
midostaurin: a step forward in the treatment of flt3-mutated aml
-
3:15
developments in targeted aml therapies: venetoclax, quizartinib & gilteritinib
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
2:41
can gilteritinib cure aml? #aml
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
1:33
is gilteritinib the new breakthrough in the treatment of flt3-mutated aml?
-
2:29
combining menin/flt3/bcl2 inhibition as a treatment approach in flt3/npm1 double mutated aml
-
2:08
comparing midostaurin to next-generation flt3 inhibitors in the frontline treatment of flt3-itd aml
-
1:35
ev-302: advancing treatment for metastatic urothelial carcinoma
-
1:48
venetoclax plus azacitidine in flt3-mutated aml
-
3:01
admiral: gilteritinib for r/r flt3-mutated aml
-
2:22
peripherin as a biomarker for als
-
2:42
triplet combination of azacitidine, venetoclax & gilteritinib for patients with flt3-mutated aml
-
0:53
javier ardines, el edil de llanes de iu, fue asesinado a golpes
-
1:28
quizartinib provides clinical benefit in r/r flt3-itd aml
-
4:09
quantum-r: quizartinib looks promising for flt3-itd mutated aml